Table 1—

Baseline characteristics of the people randomized and receiving treatment

IDet12hIDetmorn+bedNPH
n137139132
Age (years)40.9 ± 13.041.3 ± 11.438.3 ± 12.4
Sex (M/F)71/6679/6070/62
Weight (kg)74.2 ± 12.675.0 ± 12.375.5 ± 14.0
BMI (kg/m2)25.1 ± 3.325.2 ± 3.625.2 ± 3.7
Diabetes duration (years)17.1 ± 10.617.6 ± 10.715.1 ± 10.6
FPG (mmol/l)11.57 ± 4.6511.65 ± 4.6112.20 ± 5.49
HbA1c8.55 ± 1.208.74 ± 1.208.52 ± 1.19
Insulin dose (units/day)*
 Basal26.4 ± 10.828.1 ± 12.529.5 ± 13.7
 Mealtime30.9 ± 12.929.4 ± 13.430.5 ± 13.4
  • Data are means ± SD.

  • *

    * Does not include people using premix insulin at study start.